132 related articles for article (PubMed ID: 8676537)
1. Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy.
Fabbri A; Magrini N; Bianchi G; Zoli M; Marchesini G
JPEN J Parenter Enteral Nutr; 1996; 20(2):159-64. PubMed ID: 8676537
[TBL] [Abstract][Full Text] [Related]
2. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
Marchesini G; Dioguardi FS; Bianchi GP; Zoli M; Bellati G; Roffi L; Martines D; Abbiati R
J Hepatol; 1990 Jul; 11(1):92-101. PubMed ID: 2204661
[TBL] [Abstract][Full Text] [Related]
3. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.
Eriksson LS; Persson A; Wahren J
Gut; 1982 Oct; 23(10):801-6. PubMed ID: 6749604
[TBL] [Abstract][Full Text] [Related]
4. Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review.
Metcalfe EL; Avenell A; Fraser A
Clin Nutr; 2014 Dec; 33(6):958-65. PubMed ID: 24656171
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of portosystemic encephalopathy with oral branched-chain amino acids--a case report.
Fukuda K; Yao H; Murai K; Ibayashi S; Fujishima M
Fukuoka Igaku Zasshi; 1999 Dec; 90(12):464-9. PubMed ID: 10655667
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.
Horst D; Grace ND; Conn HO; Schiff E; Schenker S; Viteri A; Law D; Atterbury CE
Hepatology; 1984; 4(2):279-87. PubMed ID: 6706302
[TBL] [Abstract][Full Text] [Related]
7. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
Les I; Doval E; García-Martínez R; Planas M; Cárdenas G; Gómez P; Flavià M; Jacas C; Mínguez B; Vergara M; Soriano G; Vila C; Esteban R; Córdoba J
Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220
[TBL] [Abstract][Full Text] [Related]
8. Do branched chain amino acids improve hepatic encephalopathy in cirrhosis?
Vergara M; Castro-Gutiérrez V; Rada G
Medwave; 2016 Dec; 16(Suppl5):e6795. PubMed ID: 28024140
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study.
Plauth M; Egberts EH; Hamster W; Török M; Müller PH; Brand O; Fürst P; Dölle W
J Hepatol; 1993 Mar; 17(3):308-14. PubMed ID: 8315258
[TBL] [Abstract][Full Text] [Related]
10. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study.
Egberts EH; Schomerus H; Hamster W; Jürgens P
Gastroenterology; 1985 Apr; 88(4):887-95. PubMed ID: 3882509
[TBL] [Abstract][Full Text] [Related]
11. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial.
Sieg A; Walker S; Czygan P; Gärtner U; Lanzinger-Rossnagel G; Stiehl A; Kommerell B
Z Gastroenterol; 1983 Nov; 21(11):644-50. PubMed ID: 6362243
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hepatic encephalopathy with branched-chain amino acids (BCAA) by oral route: II. Chronic hepatic encephalopathy].
Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
Rev Esp Enferm Apar Dig; 1987 Sep; 72(3):201-5. PubMed ID: 3685578
[No Abstract] [Full Text] [Related]
13. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.
Rossi Fanelli F; Cangiano C; Capocaccia L; Cascino A; Ceci F; Muscaritoli M; Giunchi G
Gut; 1986 Nov; 27 Suppl 1(Suppl 1):111-5. PubMed ID: 3539709
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of chronic hepatic encephalopathy with branched-chain amino acids and their keto analogs].
Walker S; Bode JC
Med Klin (Munich); 1986 Aug; 81(17):567-71. PubMed ID: 3785044
[No Abstract] [Full Text] [Related]
15. [Branched-chain amino acids in the treatment of latent porto-systemic encephalopathy. A placebo-controlled double-blind cross-over study].
Egberts EH; Schomerus H; Hamster W; Jürgens P
Z Ernahrungswiss; 1986 Mar; 25(1):9-28. PubMed ID: 3524038
[TBL] [Abstract][Full Text] [Related]
16. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: meta analysis.
DerSimonian R
Hepatology; 1990 Jun; 11(6):1083-4. PubMed ID: 2142117
[No Abstract] [Full Text] [Related]
17. [Clinical evaluation of branched chain amino acids for treatment of hepatic encephalopathy].
Ker CG; Sheen PC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1986 Apr; 2(4):228-33. PubMed ID: 3482889
[No Abstract] [Full Text] [Related]
18. Parenteral branched-chain amino acids for hepatic encephalopathy. What is the grade of recommendation?
Minicucci MF; Azevedo PS; Paiva SA
Clin Nutr; 2011 Feb; 30(1):131; author reply 132. PubMed ID: 20719410
[No Abstract] [Full Text] [Related]
19. Clinical study of an enteral branched-chain amino acid solution in decompensated liver cirrhosis with hepatic encephalopathy.
Ichida T; Shibasaki K; Muto Y; Satoh S; Watanabe A; Ichida F
Nutrition; 1995; 11(2 Suppl):238-44. PubMed ID: 7626911
[No Abstract] [Full Text] [Related]
20. Nutritional treatment with branched-chain amino acids in advanced liver cirrhosis.
Marchesini G; Bianchi G; Rossi B; Brizi M; Melchionda N
J Gastroenterol; 2000; 35 Suppl 12():7-12. PubMed ID: 10779207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
